Literature DB >> 16997002

Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia.

Barbara K Lipska1, Amy Deep-Soboslay, Cynthia Shannon Weickert, Thomas M Hyde, Catherine E Martin, Mary M Herman, Joel E Kleinman.   

Abstract

BACKGROUND: Studies of postmortem human brain are important for investigating underlying pathogenic molecular mechanisms of neuropsychiatric disorders. They are, however, confounded by pre- and postmortem factors. The purpose of this study was to identify sources of variation that will enable a better design of gene expression studies and higher reliability of gene expression data.
METHODS: We assessed the contribution of multiple variables to messenger RNA (mRNA) expression of reference (housekeeping) genes measured by reverse transcriptase-polymerase chain reaction (RT-PCR) by multiple regression analysis in a large number (N = 143) of autopsy samples from the hippocampus and white and grey matter of the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia and normal control subjects.
RESULTS: The strongest predictor of gene expression was total RNA quality. Other significant factors included pH, postmortem interval, age and the duration of the agonal state, but the importance of these factors depended on transcript measured, brain region analyzed, and diagnosis. The quality of RNA obtained from the DLPFC white matter was also adversely affected by smoking.
CONCLUSIONS: Our results show that normalization of expression data of target genes with a geometric mean of multiple housekeeping genes should be used to control for differences in RNA quality between samples. The results also suggest that accurate assessment of other confounding factors and their inclusion as regressors in the analysis is critical for obtaining reliable and accurate quantification of mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997002     DOI: 10.1016/j.biopsych.2006.06.019

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  129 in total

1.  Genetic variation in FGF20 modulates hippocampal biology.

Authors:  Herve Lemaitre; Venkata S Mattay; Fabio Sambataro; Beth Verchinski; Richard E Straub; Joseph H Callicott; Raja Kittappa; Thomas M Hyde; Barbara K Lipska; Joel E Kleinman; Ronald McKay; Daniel R Weinberger
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

2.  DNA methylation signatures in development and aging of the human prefrontal cortex.

Authors:  Shusuke Numata; Tianzhang Ye; Thomas M Hyde; Xavier Guitart-Navarro; Ran Tao; Michael Wininger; Carlo Colantuoni; Daniel R Weinberger; Joel E Kleinman; Barbara K Lipska
Journal:  Am J Hum Genet       Date:  2012-02-02       Impact factor: 11.025

Review 3.  Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains.

Authors:  Joel E Kleinman; Amanda J Law; Barbara K Lipska; Thomas M Hyde; Justin K Ellis; Paul J Harrison; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2011-01-15       Impact factor: 13.382

4.  Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia.

Authors:  Shruti N Mitkus; Thomas M Hyde; Radhakrishna Vakkalanka; Bhaskar Kolachana; Daniel R Weinberger; Joel E Kleinman; Barbara K Lipska
Journal:  Schizophr Res       Date:  2007-10-26       Impact factor: 4.939

5.  Evaluation of tissue collection for postmortem studies of bipolar disorder.

Authors:  Amy Deep-Soboslay; Bianca Iglesias; Thomas M Hyde; Llewelyn B Bigelow; Vesna Imamovic; Mary M Herman; Joel E Kleinman
Journal:  Bipolar Disord       Date:  2008-11       Impact factor: 6.744

6.  Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.

Authors:  S S Kaalund; E N Newburn; T Ye; R Tao; C Li; A Deep-Soboslay; M M Herman; T M Hyde; D R Weinberger; B K Lipska; J E Kleinman
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

7.  Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity.

Authors:  Rungnapa Hirunsatit; Elizabeth D George; Barbara K Lipska; Hani M Elwafi; Lisa Sander; Carolyn M Yrigollen; Joel Gelernter; Elena L Grigorenko; Jaakko Lappalainen; Shrikant Mane; Angus C Nairn; Joel E Kleinman; Arthur A Simen
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

Review 8.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

9.  Transcriptional correlates of human substance use.

Authors:  Elin Lehrmann; William J Freed
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development.

Authors:  Clare Paterson; Yanhong Wang; Joel E Kleinman; Amanda J Law
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.